JP2016512537A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512537A5
JP2016512537A5 JP2016501522A JP2016501522A JP2016512537A5 JP 2016512537 A5 JP2016512537 A5 JP 2016512537A5 JP 2016501522 A JP2016501522 A JP 2016501522A JP 2016501522 A JP2016501522 A JP 2016501522A JP 2016512537 A5 JP2016512537 A5 JP 2016512537A5
Authority
JP
Japan
Prior art keywords
stable
prescription
ara
allergen
months
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016501522A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512537A (ja
JP6752140B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/024401 external-priority patent/WO2014159607A1/en
Publication of JP2016512537A publication Critical patent/JP2016512537A/ja
Publication of JP2016512537A5 publication Critical patent/JP2016512537A5/ja
Priority to JP2019034083A priority Critical patent/JP6891205B2/ja
Application granted granted Critical
Publication of JP6752140B2 publication Critical patent/JP6752140B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016501522A 2013-03-14 2014-03-12 経口脱感作のための落花生処方物の製造 Active JP6752140B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019034083A JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784964P 2013-03-14 2013-03-14
US61/784,964 2013-03-14
PCT/US2014/024401 WO2014159607A1 (en) 2013-03-14 2014-03-12 Manufacture of peanut formulations for oral desensitization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019034083A Division JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造

Publications (3)

Publication Number Publication Date
JP2016512537A JP2016512537A (ja) 2016-04-28
JP2016512537A5 true JP2016512537A5 (cg-RX-API-DMAC10.html) 2017-04-20
JP6752140B2 JP6752140B2 (ja) 2020-09-09

Family

ID=51528061

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016501522A Active JP6752140B2 (ja) 2013-03-14 2014-03-12 経口脱感作のための落花生処方物の製造
JP2019034083A Active JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造
JP2021025462A Active JP7454519B2 (ja) 2013-03-14 2021-02-19 経口脱感作のための落花生処方物の製造

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019034083A Active JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造
JP2021025462A Active JP7454519B2 (ja) 2013-03-14 2021-02-19 経口脱感作のための落花生処方物の製造

Country Status (19)

Country Link
US (5) US9198869B2 (cg-RX-API-DMAC10.html)
EP (3) EP3482771B1 (cg-RX-API-DMAC10.html)
JP (3) JP6752140B2 (cg-RX-API-DMAC10.html)
CN (2) CN109125283A (cg-RX-API-DMAC10.html)
AU (5) AU2014240404B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015021756B1 (cg-RX-API-DMAC10.html)
CA (1) CA2903229A1 (cg-RX-API-DMAC10.html)
DK (2) DK2968529T3 (cg-RX-API-DMAC10.html)
ES (2) ES2826224T3 (cg-RX-API-DMAC10.html)
FI (2) FI3482771T3 (cg-RX-API-DMAC10.html)
FR (1) FR23C1026I2 (cg-RX-API-DMAC10.html)
HU (1) HUE051831T2 (cg-RX-API-DMAC10.html)
MX (1) MX2015010315A (cg-RX-API-DMAC10.html)
NL (1) NL301236I2 (cg-RX-API-DMAC10.html)
NO (1) NO2023027I1 (cg-RX-API-DMAC10.html)
PL (1) PL2968529T3 (cg-RX-API-DMAC10.html)
PT (1) PT2968529T (cg-RX-API-DMAC10.html)
SI (1) SI2968529T1 (cg-RX-API-DMAC10.html)
WO (1) WO2014159607A1 (cg-RX-API-DMAC10.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
MX2015010315A (es) 2013-03-14 2016-04-13 Aimmune Therapeutics Inc Fabricacion de formulaciones de mani para desensibilizacion oral.
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
JP6910946B2 (ja) 2014-08-25 2021-07-28 アイミューン セラピューティクス,インコーポレイテッド タマゴのタンパク質製剤およびその製造方法
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
WO2016134291A2 (en) 2015-02-20 2016-08-25 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
TW201709926A (zh) * 2015-04-23 2017-03-16 賽諾菲公司 用於舌下投藥之吡喃葡萄糖基脂a及過敏原調配物
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
PT3548079T (pt) * 2016-12-05 2023-07-27 Reacta Biotech Ltd Formulações de refeições para provocação oral
CN110381749A (zh) * 2017-01-13 2019-10-25 艾慕恩治疗公司 坚果粉的制造方法和用于口服免疫疗法的配方
AU2017279647B2 (en) 2017-02-15 2022-05-26 Euroimmun Medizinische Labordiagnostika Ag An improved assay for the diagnosis of peanut allergy
CN111465328A (zh) 2017-07-18 2020-07-28 前品牌股份有限公司 制备混合型变应原组合物的方法
US11369676B2 (en) 2017-11-02 2022-06-28 Société des Produits Nestlé S.A. Methods of oral immunotherapy
GB201718342D0 (en) * 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
EP3740223A4 (en) 2018-01-16 2021-10-20 Tel HaShomer Medical Research Infrastructure and Services Ltd. TREATMENT AND PREVENTION OF SEED ALLERGIES
US11406563B2 (en) 2018-07-27 2022-08-09 Société des Produits Nestlé S.A. Oral immunotherapy unit dose dispensing systems and methods
US12433945B2 (en) 2018-08-16 2025-10-07 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
AU2019401576A1 (en) * 2018-12-17 2021-06-24 Société des Produits Nestlé S.A. Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
CA3123605A1 (en) * 2018-12-20 2020-06-25 Aimmune Therapeutics, Inc. Peanut oral immunotherapy dosing schedule for missed doses
US11766477B2 (en) 2019-01-23 2023-09-26 Societe Des Produits Nestle S.A. Methods for making mixed allergen compositions
CA3137295A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy
ES3038192T3 (en) * 2019-08-08 2025-10-10 Evonik Operations Gmbh Method of preparing a solid dosage form and a lubricant
WO2021102186A1 (en) * 2019-11-20 2021-05-27 Aimmune Therapeutics, Inc. Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug
AU2020410909A1 (en) * 2019-12-23 2022-07-14 Prota Therapeutics Pty Ltd Pharmaceutical compositions
JP7756664B2 (ja) 2020-07-01 2025-10-20 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 経口免疫療法のための医療スタッフ配置の決定
US20220220211A1 (en) 2021-01-08 2022-07-14 Regeneron Pharmaceuticals, Inc. Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
US20250325658A1 (en) 2022-04-11 2025-10-23 Alk-Abelló A/S Peanut allergen compositions

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809767A (en) 1969-05-12 1974-05-07 Griffith Laboratories Methods of making vegetable protein concentrates
AU1589492A (en) 1991-03-01 1992-10-06 Warner-Lambert Company Starch-based controlled release compositions
US20120164306A1 (en) * 1993-08-03 2012-06-28 Girsh Leonard S Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) * 1994-09-10 2003-09-08 株式会社林原生物化学研究所 ペプチドとその用途
US20020018778A1 (en) 1999-12-06 2002-02-14 Caplan Michael J. Passive desensitization
EP1272213B1 (en) * 2000-04-06 2006-03-08 SEER Pharmaceuticals, LLC. Microbial delivery system
CA2516291C (en) 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
EP2545931A1 (en) 2004-03-19 2013-01-16 Herbs Spring, LLC Herbal therapy for the treatment of food allergy
WO2007075171A1 (en) 2005-12-28 2007-07-05 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of fenofibrate having improved bioavailability
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
CN102215825A (zh) 2008-11-19 2011-10-12 安万托特性材料股份有限公司 可直接压制的颗粒状的基于微晶纤维素的赋形剂、其制备方法及应用
WO2010069595A1 (en) 2008-12-19 2010-06-24 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (en) * 2010-02-12 2011-09-14 Centro De Ingenieria Genetica Y Biotecnologia Orally administrable pharmaceutical pellet of epidermal growth factor
JP5800527B2 (ja) 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
AR081776A1 (es) 2010-06-30 2012-10-17 Novartis Ag Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion
CN101912364B (zh) * 2010-08-09 2015-07-15 刘会梅 银杏内酯b脂质体组合药物
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
EP2750705B1 (en) * 2011-08-31 2022-11-16 Perosphere Technologies Inc. Methods for effectively and rapidly desensitizing allergic patients
WO2013087119A1 (en) 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
MX2015010315A (es) 2013-03-14 2016-04-13 Aimmune Therapeutics Inc Fabricacion de formulaciones de mani para desensibilizacion oral.
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
JP6910946B2 (ja) 2014-08-25 2021-07-28 アイミューン セラピューティクス,インコーポレイテッド タマゴのタンパク質製剤およびその製造方法
CN110381749A (zh) 2017-01-13 2019-10-25 艾慕恩治疗公司 坚果粉的制造方法和用于口服免疫疗法的配方
US11369676B2 (en) 2017-11-02 2022-06-28 Société des Produits Nestlé S.A. Methods of oral immunotherapy

Similar Documents

Publication Publication Date Title
JP2015520667A5 (cg-RX-API-DMAC10.html)
JP2017500760A5 (cg-RX-API-DMAC10.html)
TR201909746T4 (tr) Pestisit işlevine sahip moleküller ve bunlarla ilişkili ara maddeler, bileşim ve işlemler.
JP2015081257A5 (cg-RX-API-DMAC10.html)
JP2016508542A5 (cg-RX-API-DMAC10.html)
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
JP2016511287A5 (cg-RX-API-DMAC10.html)
CY1118746T1 (el) Μεθοδοι συνθεσης και καθαρισμου για ενωσεις φωσφαπλατινης και χρησεις αυτων
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof
PE20151789A1 (es) N-(2-fluoro-2-fenetil)carboxamidas como nematicidas y endoparasiticidas
DK3601252T3 (da) Tetrahydrat af H3-ligand, fremgangsmåde til fremstilling deraf og farma-ceutiske sammensætninger omfattende samme
EP3651587A4 (en) COMPOSITIONS RICH IN PROTEIN AND THEIR PREPARATION AND USE PROCESS
RU2015126587A (ru) Способ повышения урожайности озимой пшеницы
CN106414485A8 (zh) 人工活化的毒性肽
CN302508771S (zh) 床屏饰件(蝶形)
JP2015055527A5 (cg-RX-API-DMAC10.html)
CN301976126S (zh) 黄金制品(五方文殊金章)
CN302323913S (zh) 揉面机(kf-106)
CN302094599S (zh) 揉面机(kf-105)
CN302386435S (zh) 饼(相思饼)
CN301852900S (zh) 对戒(“穿越时空的爱”同坯对戒-9)
TH156083A (th) กรรมวิธีการดัดแปลงแป้งกล้วยโดยการดัดแปรทางเคมีเพื่อใช้ในอุตสาหกรรมเครื่องสำอาง
CN302105073S (zh) 烤箱旋钮(9系列)
TH171335A (th) อนุพันธ์ไอซอกซาโซลิดีน
CN302277783S (zh) 包装管(洁面粉)